浙江省人民政府

Zhejiang became the first Chinese province to reimburse a BCI service when it covered non-invasive fitting fees under Category B insurance from September 1, 2025, limited to smart bionic prosthesis fittings. Its 18 industry-academia-research measures, dated July 16, 2026, cut review of qualifying Class II BCI devices to 40 working days and offer research hospitals up to RMB 8 million per project.

The General Office of China's Zhejiang Provincial People's Government issued Several Measures for Promoting Industry-University-Research Coordination in Brain-Computer Interfaces, document number Zhe Zheng Ban Fa [2026] No. 33, dated July 16, 2026 and released on August 12, comprising 18 measures in five areas. Class II BCI devices of clear clinical value may enter a special review procedure with the timeline cut to within 40 working days, while medical consumables are listed through a green channel within 10 working days. Funding comes in four tiers: up to 10 million yuan for a provincial major science and technology project, up to 8 million yuan for research hospitals deeply involved in preclinical work and product launch, up to 3 million yuan for applied basic research, and 1 million, 500,000 and 100,000 yuan for leading international, national and local standards. Beds used solely for clinical research are exempt from efficiency and DRG performance assessment.